Clinical Trials Browser

Phase 3 × OTHER × elotuzumab × Clear all

NCT05675319 2026-01-05

AlloRelapseMM

Phase 3 Terminated

Multiple Myeloma

NCT03948035 2023-05-06

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

Phase 3 Active not recruiting

Multiple Myeloma

NCT02495922 2021-09-10

GMMG-HD6

Phase 3 Completed

Multiple Myeloma